Internal Medicine · West Hollywood, CA
NPI
1659550473
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8700 Beverly Blvd # 5512, Department of Internal Medicine
West Hollywood, CA, 90048
Phone (310) 423-5581
Groups this clinician bills Medicare through
Medicare paid, 2024
$399K
3,508 services
Medicare patients, 2024
881
Average age 79
Drug cost, 2024
$734K
4,617 prescriptions
Company payments, 2025
$2,607
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kambiz Vahabzadeh was code 99214 (office e&m - established), 1,208 times for 596 patients. In total Kambiz Vahabzadeh billed 3,508 services in 19 codes, and Medicare paid $399K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,208 | 596 | $92.87 | $112K |
| 99215 Office E&M - Established | Office | 482 | 283 | $110.38 | $53K |
| 99232 Hospital E&M - Subsequent | Facility | 474 | 113 | $66.19 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 456 | 154 | $100.11 | $46K |
| 99205 Office E&M - New | Office | 166 | 166 | $179.26 | $30K |
| 99223 Hospital E&M - Initial | Facility | 150 | 120 | $143.10 | $21K |
| 90961 ESRD Related Services (not dialysis) | Office | 106 | 26 | $240.11 | $25K |
| 99213 Office E&M - Established | Office | 67 | 50 | $75.60 | $5,065 |
| 99291 Critical Care E&M | Facility | 67 | 25 | $172.59 | $12K |
| 90962 ESRD Related Services (not dialysis) | Office | 66 | 25 | $168.90 | $11K |
| 90960 ESRD Related Services (not dialysis) | Office | 62 | 19 | $300.48 | $19K |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 49 | 44 | $211.78 | $10K |
| 90935 Hemodialysis | Facility | 29 | 18 | $56.81 | $1,648 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 27 | 25 | $124.55 | $3,363 |
By year: 2022 $386K for 3,291 services; 2023 $376K for 3,417 services; 2024 $399K for 3,508 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kambiz Vahabzadeh prescribed most often to Medicare patients was Amlodipine Besylate, with 469 prescriptions and refills. In total Kambiz Vahabzadeh wrote 4,617 Medicare prescriptions that cost $734K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 469 | 1,229 | 156 | $3,045 |
| Farxiga Dapagliflozin Propanediol | 371 | 565 | 75 | $309K |
| Losartan Potassium Generic | 318 | 862 | 102 | $4,079 |
| Allopurinol Generic | 182 | 459 | 55 | $1,749 |
| Furosemide Generic | 161 | 369 | 55 | $709 |
| Spironolactone Generic | 148 | 378 | 51 | $1,410 |
| Atorvastatin Calcium Generic | 147 | 333 | 38 | $1,304 |
| Metoprolol Succinate Generic | 132 | 331 | 40 | $2,372 |
| Paricalcitol Generic | 130 | 278 | 39 | $11K |
| Hydralazine Hcl Generic | 116 | 266 | 41 | $1,463 |
| Hydrochlorothiazide Generic | 95 | 245 | 34 | $697 |
| Rosuvastatin Calcium Generic | 92 | 276 | 31 | $1,773 |
| Lisinopril Generic | 91 | 242 | 32 | $439 |
| Valsartan Generic | 86 | 227 | 25 | $2,200 |
| Tamsulosin Hcl Generic | 86 | 219 | 31 | $1,049 |
Brand drugs: - claims; generic drugs: 3,926 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kambiz Vahabzadeh $2,607 ($2,607 in general payments such as food, travel and fees) from 23 companies. The largest payer was Ardelyx, Inc. with $369.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 17 | $369 |
| Mallinckrodt Hospital Products Inc. | 11 | $245 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $223 |
| Vifor Pharma, Inc. | 8 | $200 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $187 |
| Travere Therapeutics, Inc. TVTX | 10 | $180 |
| Apellis Pharmaceuticals, Inc. APLS | 9 | $163 |
| Veloxis Pharmaceuticals, Inc. | 3 | $149 |
| Novo Nordisk Inc NVO | 5 | $101 |
| Calliditas Therapeutics US Inc. | 4 | $99.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.